14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.72 $7.24 Wednesday, 24th Apr 2024 AFMD stock ended at $4.88. This is 8.79% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 11.72% from a day low at $4.87 to a day high of $5.44.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Jan 07, 2022 $50.20 $51.70 $48.10 $48.20 155 100
Jan 06, 2022 $49.70 $51.10 $48.35 $50.40 119 140
Jan 05, 2022 $53.00 $53.70 $49.55 $49.70 103 340
Jan 04, 2022 $56.80 $56.90 $53.05 $53.60 78 044
Jan 03, 2022 $55.50 $57.60 $55.20 $56.50 74 302
Dec 31, 2021 $56.40 $57.70 $55.20 $55.20 56 893
Dec 30, 2021 $55.50 $58.35 $55.40 $56.90 76 185
Dec 29, 2021 $55.70 $56.00 $54.70 $55.10 45 904
Dec 28, 2021 $56.90 $57.90 $55.70 $55.90 64 330
Dec 27, 2021 $59.00 $59.90 $56.35 $57.00 82 520
Dec 23, 2021 $56.90 $59.10 $56.20 $59.10 61 603
Dec 22, 2021 $57.30 $58.10 $56.65 $57.10 58 451
Dec 21, 2021 $57.00 $58.30 $56.10 $57.40 67 393
Dec 20, 2021 $56.00 $57.80 $54.50 $56.70 66 706
Dec 17, 2021 $54.40 $57.70 $53.00 $56.50 101 197
Dec 16, 2021 $57.65 $57.95 $54.20 $54.80 95 668
Dec 15, 2021 $53.60 $56.70 $52.10 $56.50 194 335
Dec 14, 2021 $55.30 $56.20 $53.20 $53.70 173 995
Dec 13, 2021 $60.00 $60.00 $55.35 $56.00 192 437
Dec 10, 2021 $62.50 $63.20 $57.20 $58.90 251 325
Dec 09, 2021 $68.80 $69.10 $61.90 $62.50 294 391
Dec 08, 2021 $65.80 $69.00 $64.00 $68.30 152 292
Dec 07, 2021 $61.50 $66.00 $61.50 $64.50 300 719
Dec 06, 2021 $59.90 $61.35 $57.10 $61.00 191 076
Dec 03, 2021 $66.60 $66.70 $59.40 $60.70 336 721
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT